S&P 500   3,368.01 (+0.22%)
DOW   28,001.33 (+0.76%)
QQQ   268.43 (-0.70%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
S&P 500   3,368.01 (+0.22%)
DOW   28,001.33 (+0.76%)
QQQ   268.43 (-0.70%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
S&P 500   3,368.01 (+0.22%)
DOW   28,001.33 (+0.76%)
QQQ   268.43 (-0.70%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
S&P 500   3,368.01 (+0.22%)
DOW   28,001.33 (+0.76%)
QQQ   268.43 (-0.70%)
AAPL   443.42 (-1.66%)
MSFT   206.16 (-1.00%)
FB   260.38 (-1.00%)
GOOGL   1,498.00 (+0.08%)
AMZN   3,121.05 (-0.86%)
NVDA   438.62 (-1.79%)
CGC   17.44 (-2.73%)
BABA   249.78 (+0.66%)
TSLA   1,392.00 (-1.87%)
GE   6.80 (+1.95%)
MU   48.65 (-1.02%)
AMD   78.80 (-4.18%)
T   30.45 (+0.83%)
F   7.32 (+3.24%)
ACB   10.12 (-0.98%)
GILD   68.06 (-0.66%)
NFLX   471.24 (-2.51%)
DIS   131.82 (+2.35%)
BAC   27.25 (+2.60%)
BA   186.10 (+3.73%)
Log in

NASDAQ:MOTSMotus GI Stock Price, Forecast & News

$1.23
-0.02 (-1.60 %)
(As of 08/11/2020 02:51 PM ET)
Add
Compare
Today's Range
$1.19
Now: $1.23
$1.24
50-Day Range
$1.18
MA: $1.26
$1.42
52-Week Range
$0.46
Now: $1.23
$2.99
Volume1,051 shs
Average Volume48,390 shs
Market Capitalization$35.50 million
P/E RatioN/A
Dividend YieldN/A
Beta2.99
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.
Read More
Motus GI logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.53 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MOTS
CUSIPN/A
Phone954-541-8000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$110,000.00
Book Value$0.64 per share

Profitability

Net Income$-23,090,000.00
Net Margins-17,405.97%

Miscellaneous

Employees44
Market Cap$35.50 million
Next Earnings Date8/11/2020 (Confirmed)
OptionableNot Optionable
$1.23
-0.02 (-1.60 %)
(As of 08/11/2020 02:51 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Motus GI (NASDAQ:MOTS) Frequently Asked Questions

How has Motus GI's stock price been impacted by Coronavirus (COVID-19)?

Motus GI's stock was trading at $1.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MOTS shares have increased by 18.3% and is now trading at $1.23.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Motus GI?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Motus GI
.

When is Motus GI's next earnings date?

Motus GI is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020.
View our earnings forecast for Motus GI
.

How were Motus GI's earnings last quarter?

Motus GI Holdings Inc (NASDAQ:MOTS) issued its earnings results on Thursday, May, 14th. The company reported ($0.23) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.22) by $0.01. The business earned $0.03 million during the quarter, compared to the consensus estimate of $0.15 million. Motus GI had a negative return on equity of 148.97% and a negative net margin of 17,405.97%.
View Motus GI's earnings history
.

What price target have analysts set for MOTS?

3 equities research analysts have issued 1-year target prices for Motus GI's stock. Their forecasts range from $3.00 to $7.00. On average, they anticipate Motus GI's share price to reach $4.00 in the next year. This suggests a possible upside of 225.2% from the stock's current price.
View analysts' price targets for Motus GI
.

Has Motus GI been receiving favorable news coverage?

News coverage about MOTS stock has trended neutral this week, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Motus GI earned a media sentiment score of 0.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.
View the latest news about Motus GI
.

Who are some of Motus GI's key competitors?

What other stocks do shareholders of Motus GI own?

Who are Motus GI's key executives?

Motus GI's management team includes the following people:
  • Mr. Timothy P. Moran, CEO & Director (Age 47)
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 58)
  • Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 48)

When did Motus GI IPO?

(MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $1.23.

How big of a company is Motus GI?

Motus GI has a market capitalization of $35.50 million and generates $110,000.00 in revenue each year. The company earns $-23,090,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis. Motus GI employs 44 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is www.motusgi.com.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 954-541-8000 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.